REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 36 filers reported holding REPROS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $486,000 | +89.8% | 735,447 | -8.3% | 0.00% | – |
Q3 2017 | $256,000 | -30.1% | 801,737 | +0.9% | 0.00% | – |
Q2 2017 | $366,000 | -65.7% | 794,303 | -10.7% | 0.00% | – |
Q1 2017 | $1,068,000 | -8.3% | 889,850 | +0.8% | 0.00% | – |
Q4 2016 | $1,165,000 | -41.9% | 882,436 | -8.0% | 0.00% | – |
Q3 2016 | $2,005,000 | +24.0% | 958,977 | -4.5% | 0.00% | – |
Q2 2016 | $1,617,000 | +100.9% | 1,004,041 | +21.1% | 0.00% | – |
Q1 2016 | $805,000 | -19.6% | 829,431 | +0.3% | 0.00% | – |
Q4 2015 | $1,001,000 | -82.3% | 827,190 | +8.4% | 0.00% | – |
Q3 2015 | $5,668,000 | +12.7% | 762,838 | +8.5% | 0.00% | – |
Q2 2015 | $5,029,000 | -17.2% | 703,287 | -0.5% | 0.00% | – |
Q1 2015 | $6,073,000 | -6.3% | 706,907 | +8.7% | 0.00% | – |
Q4 2014 | $6,483,000 | -0.5% | 650,225 | -1.2% | 0.00% | -100.0% |
Q3 2014 | $6,513,000 | -41.3% | 657,860 | +2.6% | 0.00% | 0.0% |
Q2 2014 | $11,097,000 | +2.7% | 641,383 | +5.3% | 0.00% | 0.0% |
Q1 2014 | $10,806,000 | +3.6% | 609,134 | +6.9% | 0.00% | 0.0% |
Q4 2013 | $10,427,000 | -29.1% | 569,763 | +3.8% | 0.00% | 0.0% |
Q3 2013 | $14,712,000 | +53.2% | 548,958 | +5.4% | 0.00% | 0.0% |
Q2 2013 | $9,606,000 | – | 520,658 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,132,367 | $11,290,000 | 4.00% |
SENZAR ASSET MANAGEMENT, LLC | 764,406 | $7,621,000 | 2.23% |
DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $3,280,000 | 0.88% |
RTW INVESTMENTS, LP | 229,364 | $2,287,000 | 0.85% |
CQS Cayman LP | 700,000 | $6,979,000 | 0.46% |
GENERAL AMERICAN INVESTORS CO INC | 508,375 | $5,068,000 | 0.40% |
Alden Global Capital Ltd | 154,000 | $1,535,000 | 0.37% |
J. Goldman & Co LP | 197,500 | $1,969,000 | 0.23% |
Baker Brothers Advisors | 2,000,000 | $19,940,000 | 0.20% |
SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $997,000 | 0.17% |